Neurocrine Biosciences Inc at William Blair Biotech Focus Conference (Virtual) Transcript
Welcome back to the William Blair Biotech Focus Conference 2021. Thanks for joining us. My name is Myles Minter. I'm a senior biotech analyst here at the firm covering neurosciences among other areas.
Just before we get started for today's panel and neuropsychiatry updates, just have to refer listeners to disclosures on williamblair.com for various forward-looking statements that each company may be or may not be making in this chat.
Additionally, there is a link to a Q&A feature at the bottom of your screen. I'm already seeing a couple of pop-up, but feel free to type in your questions at the bottom there, and we'll do our best to get those answered around the panel.
But with that, it's my pleasure to welcome the panel members. Today we have representatives from Neurocrine, Praxis Precision Medicines, VistaGen and Aptinyx. I will not go through the introductions. Rather I'll have them introduce themselves and give a brief 1-minute spill on the exciting things that are happening at each
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |